4.2 Article

Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy

Related references

Note: Only part of the references are listed.
Review Immunology

New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy

Anna Bellizzi et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)

Article Clinical Neurology

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

Stefanie Dahlhaus et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)

Article Clinical Neurology

Best practice in the use of natalizumab in multiple sclerosis

Oscar Fernandez

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)

Review Clinical Neurology

Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis

M. A. Sahraian et al.

EUROPEAN JOURNAL OF NEUROLOGY (2012)

Review Clinical Neurology

Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab

B. K. Kleinschmidt-DeMasters et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)

Editorial Material Clinical Neurology

LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL

Valerie Rigau et al.

NEUROLOGY (2012)

Article Medicine, General & Internal

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Gary Bloomgren et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Clinical Neurology

Immune reconstitution inflammatory syndrome in natalizumab-associated PML

I. L. Tan et al.

NEUROLOGY (2011)

Article Clinical Neurology

Neurological complications of immune reconstitution in HIV-infected populations

Tory Johnson et al.

YEAR IN NEUROLOGY 2 (2010)

Review Clinical Neurology

Neurologic Consequences of the Immune Reconstitution Inflammatory Syndrome (IRIS)

Micheline McCarthy et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2010)